Shaily Engineering Plastics Limited has delivered robust financial performance for Q3FY26, demonstrating strong growth across key metrics. The company's consolidated revenue increased 27% to Rs. 250.5 crores compared to Rs. 197.6 crores in Q3FY25, while profit after tax surged 48% to Rs. 37.4 crores from Rs. 25.2 crores in the corresponding period last year.

Financial Performance Highlights

The company's Q3FY26 consolidated results showcase significant improvements across all major financial parameters:

For the nine months ended December 31, 2025, the performance was even more impressive with revenue growing 32% to Rs. 753.8 crores and PAT more than doubling with 101% growth to Rs. 129.8 crores.

Segment-wise Revenue Performance

The healthcare segment emerged as the standout performer, driving overall growth momentum:

The healthcare segment's exceptional growth of 139% reflects the company's successful expansion in medical device manufacturing and drug delivery systems. The industrial segment also showed strong momentum with 87% growth, while the consumer segment experienced a temporary decline of 13%.

Strategic Expansion and Leadership Appointments

Shaily Engineering Plastics announced significant strategic initiatives during the quarter. The company plans to establish a new manufacturing facility in Abu Dhabi with an investment of AED 130-150 million, targeting a capacity of approximately 75 million pen injectors per annum. The facility is expected to become operational by Q4 FY28 and will support the global GLP-1 opportunity while expanding the company's international manufacturing footprint.

The company also appointed Mr. Joe Kam as Chief Operating Officer (Healthcare) effective March 1, 2026. With over two decades of international experience in manufacturing and operations, Kam previously held senior positions at SHL Medical and Flextronics.

Operational Metrics and Capital Efficiency

The company demonstrated improved capital efficiency with Return on Capital Employed (RoCE) increasing to 38.4% in December 2025 from 24.4% in March 2025, representing an improvement of 1,400 basis points. Return on Equity (RoE) also strengthened to 29.1% from 18.5%, marking a 1,060 basis points increase.

Machine utilization across plants showed positive trends with export utilization at 47.1% compared to domestic utilization of 44.6% in Q3FY26. The company processed 5,541 MT of polymers for export compared to 6,308 MT for domestic markets during the quarter.

Business Development Achievements

During Q3FY26, Shaily Engineering Plastics achieved several business milestones including onboarding two new customers in the fast-growing GLP-1 segment and signing two new contracts with global companies for pen injector manufacturing and supply. The company also secured new product mandates in power tool components, LED lighting applications, and home furnishing products, demonstrating its diversified growth strategy across multiple sectors.

Shaily Engineering Plastics Limited has announced its quarterly earnings call with analysts and investors to discuss the company's operational and financial performance for Q3FY26 and nine months FY26. The announcement was made through a formal communication to stock exchanges under Regulation 30 of the SEBI Listing Regulations, 2015.

Earnings Call Schedule

The earnings call is scheduled for February 13, 2026, at 4:00 PM IST. The company has arranged comprehensive access for international participants with specific timing adjustments for different regions.

Management Participation

The earnings call will be led by senior management representatives who will present and discuss the company's performance metrics for the reporting period.

Access Information

Shaily Engineering Plastics Limited has provided multiple dial-in options to accommodate participants from various geographical locations. The company has established universal dial-in numbers for India along with dedicated access numbers for international participants.

Registration and Support

The company has arranged pre-registration facilities for participants and provided dedicated support contacts through Strategic Growth Advisors Pvt. Ltd. Participants can reach out to Mr. Deven Dhruba at +91 98333 73300 or Ms. Krishna Shrimankar at +91 87797 99281 for any assistance regarding the earnings call.

The earnings call invitation and related documentation have been made available on the company's official website under the investors section. This quarterly interaction represents the company's commitment to maintaining transparent communication with its stakeholders regarding operational and financial developments for the quarter and nine months ended December 31, 2025.